Treatment of Itchy Eyes
For itchy eyes, start with dual-action topical antihistamine/mast cell stabilizers (olopatadine, ketotifen, epinastine, or azelastine) as first-line therapy, combined with cold compresses and preservative-free artificial tears. 1, 2, 3
Initial Assessment
Determine the underlying cause by evaluating:
- Allergic conjunctivitis: Bilateral itching as the predominant symptom, often with watery discharge, conjunctival injection, and history of atopy (asthma, eczema, seasonal allergies) 1, 4
- Dry eye syndrome: Symptoms of irritation, burning, soreness, ocular discomfort, or intermittent blurred vision, which may present as itching 1
- Eyelid involvement: Eczematous lesions suggesting atopic or contact dermatitis 1, 5
First-Line Treatment Algorithm
For Allergic Conjunctivitis (Most Common Cause)
Step 1: Dual-Action Agents + Non-Pharmacological Measures
Topical dual-action agents (antihistamine + mast cell stabilizer): olopatadine, ketotifen, epinastine, or azelastine twice daily 1, 2, 3
Adjunctive non-pharmacological measures:
- Apply cold compresses for several minutes to reduce inflammation 1, 2
- Use refrigerated preservative-free artificial tears 4 times daily to dilute allergens and inflammatory mediators 2, 3
- Avoid eye rubbing, which worsens symptoms and can lead to keratoconus 2, 3
- Wear sunglasses as a barrier to airborne allergens 2, 3
- Implement hypoallergenic bedding, eyelid cleansers, frequent clothes washing, and bathing before bedtime 2
Step 2: Add Mast Cell Stabilizers if Inadequate Response
- If symptoms persist after 48 hours, add a mast cell stabilizer: sodium cromoglycate (all ages), lodoxamide (>4 years), or nedocromil 1, 3
- Note that mast cell stabilizers alone have slower onset (several days) and are better for prophylactic treatment 1, 3
Step 3: Brief Course of Topical Corticosteroids for Severe Cases
- For severe symptoms or acute exacerbations, add a brief 1-2 week course of loteprednol etabonate 2, 3
- Critical monitoring requirements: Measure intraocular pressure at baseline and periodically, perform pupillary dilation to evaluate for cataract 2, 3
- Use the minimum effective dose and taper slowly 3
For Eyelid Skin Involvement
For Dry Eye Syndrome
Staged Management Approach:
- Step 1: Patient education, environmental modification, preservative-free ocular lubricants, eyelid hygiene, and warm compresses 1
- Step 2: If inadequate, add nonpreserved lubricants, punctal occlusion, topical corticosteroids (limited duration), topical cyclosporine, or topical lifitegrast 1
- Step 3: Consider topical corticosteroids for longer duration, amniotic membrane grafts, or surgical punctal occlusion 1
Critical Pitfalls to Avoid
- Never use punctal plugs in allergic conjunctivitis as they prevent flushing of allergens and inflammatory mediators 3
- Avoid prolonged use of vasoconstrictors (>10 days) as they cause rebound hyperemia (conjunctivitis medicamentosa) 1, 2, 3
- Avoid oral antihistamines as primary treatment as they may worsen dry eye syndrome and impair the tear film's protective barrier 2, 3
- Avoid topical corticosteroids in HSV conjunctivitis without antiviral coverage, as they potentiate infection 6
- Limit topical corticosteroids to 1-2 weeks maximum when used for allergic conjunctivitis to minimize risks of elevated intraocular pressure and cataract formation 2, 3
When to Refer to Ophthalmology
Urgent referral (within 24 hours to 4 weeks) is indicated for: 1, 2
- Visual loss or moderate to severe pain
- Severe purulent discharge or corneal involvement
- Lack of response to topical treatment and lid hygiene
- History of HSV eye disease or immunocompromised state
- Children <7 years with moderate to severe symptoms
- Progressive conjunctival cicatrization or significant risk to visual acuity
Special Considerations
- Intranasal corticosteroids, oral antihistamines, and intranasal antihistamines have similar effectiveness in relieving ocular symptoms associated with allergic rhinitis 1
- For severe refractory cases, consider topical cyclosporine 0.05% or tacrolimus 3
- Preservative-free formulations are essential for children under 5 years and when frequent application (>4 times daily) is needed 2